arrow
M

Michal A. Stanczak

max planck institute for immunobiology and epigenetics
H指数:26
被引数:2,945

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A STAT1/ETC/GBP1 axis represents a potential therapeutic target for noncommunicable granulomatous skin disease

STAT1/ETC/GBP1轴代表非传染性肉芽肿性皮肤疾病的潜在治疗靶点

2026-05-290
OA
Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment
2024-01-118
OAAI
Phosphoinositide acyl chain saturation drives CD8+ effector T cell signaling and function
2023-02-0216
OA
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
2023-02-0229
OAAI
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade
2022-11-0290
OA
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity
2022-07-1334
OA
Intracellular infection and immune system cues rewire adipocytes to acquire immune function
2022-05-0128
OAAI
Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters

浆细胞样树突状细胞活化依赖于不同氨基酸转运蛋白的协调表达

IMMUNITY
IF26.3
2021-11-0134
OAAI
Fever supports CD8+effector T cell responses by mitochondrial translation
2021-06-142
OAAI
Dynamic Cardiolipin Synthesis Is Required for CD8+ T Cell Immunity
2020-12-0140
OAAI
Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy

CD8效应T细胞的代谢调节用于过继细胞治疗

2020-08-0398
OAAI
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses
2019-09-0148
OAAI
A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer
2019-05-1535
OAAI